Charles River Laboratories Logo

Charles River Laboratories

🇺🇸
CRL
US1598641074

Charles River Laboratories is a leading global contract research organization (CRO) and a partner in preclinical research. The company comprehensively supports pharmaceutical and biotech clients in drug development, from discovery to manufacturing. It provides critical laboratory services and animal models to accelerate therapeutic advancements and ensure the safe market launch of new medicines.

Next Quarterly Earnings

Wednesday, November 11, 2026
CW 46
Pre-Market
In 76 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 14, 2026

Stock Price

Frequently asked questions

When will Charles River Laboratories report its next quarterly earnings?

Charles River Laboratories is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Charles River Laboratories last report quarterly earnings?

Charles River Laboratories last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 3.02 USD.

How does Charles River Laboratories stock react to earnings?

Across its last 3 earnings reports, Charles River Laboratories stock moved by ±2% on average the following day. The largest reaction was -5.7% on 11/05/2025; 0 of 3 reactions were positive.

How often has Charles River Laboratories beaten expectations?

Charles River Laboratories has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).

How do I add the Charles River Laboratories earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$2.96
Actual:
Q2 2026
Beat
Estimate:$2.74
Actual:$3.02
Difference:+$0.28
Q1 2026
Beat
Estimate:$1.94
Actual:$2.06
Difference:+$0.12
Price reaction (1 day):0.0 %
Price reaction (7 days):-12.4 %
Q4 2025
Beat
Estimate:$2.35
Actual:$2.39
Difference:+$0.04
Price reaction (1 day):-0.3 %
Price reaction (7 days):+5.7 %
Q3 2025
Beat
Estimate:$2.34
Actual:$2.43
Difference:+$0.09
Price reaction (1 day):-5.7 %
Price reaction (7 days):-3.6 %
Q1 2025
Beat
Estimate:$2.55
Actual:$3.12
Difference:+$0.57

Earnings statistics

Stock reaction to earnings

±2%
Avg. next-day move
-5.7%
Largest move (11/05/2025)
0%
Share of positive reactions
±7.2%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

5/5
Quarters above estimates
100%
Beat rate
+3.7%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Charles River Laboratories
Ticker Symbol
CRL
ISIN
US1598641074
Country
🇺🇸
USA
Sector